FDA Investigator Teegan Dellibovi Ragheb, PhD

Teegan Dellibovi Ragheb, PhD has conducted inspections on 2 sites in 1 countries as of 01 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
2
Last Inspection Date:
01 Dec 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100011311
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Teegan Dellibovi Ragheb, PhD:
Alice S Tsao, Amy Devlin, PhD, Anastasia G Lolas, Andrea Siegel, PhD, Andrew "Drew" Haack, PhD, Andrew K Haack, PhD, Anita Narula, PhD, Anjali Shukla, PhD, Arie C Menachem, Barbara Janine Breithaupt, Bo Chi, PhD, Brian M Janelsins, PhD, Brooke K Higgins, CDR Donald Ertel, Chaltu Nwakijra, Charles Yuanchia Kuo, PhD, Chava Kimchi Sarfaty, PhD, Christopher R Czajka, Colleen F Hoyt, Deborah M Trout, Donald C Obenhuber, PhD, Dr. Zhihao Qiu (Peter), PhD, Frances Namuswe, PhD, Jee Chung, PhD, Jennifer Swisher, PhD, Joan Johnson, Jonathan W Chapman, Kalavati Suvarna, PhD, Kathryn E King, Kathy Lee, Lisa K Capron, LT Richard A Lyght, Madushini Dharmasena, PhD, Maria Gutierrez Lugo, PhD, Mary E Farbman, PhD, Michael S Araneta, Michael Shanks, MS, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Nataniel Phillips Sylvain, PhD, Nebil A Oumer, Prabhu P Raju, Rabia Ballica, PhD, Rachel C Harrington, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, S Lori Brown, PhD MPH, Scott R Nichols, PhD, Shadia Zaman, PhD, Steven E Bowen, PhD, Thuy T Nguyen, LCDR, V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Wayne E Seifert, Wendy G Tan, PhD, Xiaoshi N Wang, Yideng Liang, Yuan Chia Kuo, Zhong Li, PhD

Teegan Dellibovi Ragheb, PhD's Documents

Publish Date Document Type Title
December, 2023 FDA 483 Human Genome Sciences, Inc. - Form 483, 2023-12-11
February, 2023 FDA 483 AGC Biologics, Inc. - Form 483, 2023-02-10
February, 2023 EIR AGC Biologics, Inc. - EIR, 2023-05-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more